Cargando…
Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms
A simple, rapid, sensitive, and precise reversed-phase liquid chromatographic method was developed and validated for the simultaneous determination of four direct-acting antivirals, sofosbuvir (SF), ledipasvir (LD), declatasvir (DC), and simeprevir (SM), in their respective pharmaceutical formulatio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587186/ https://www.ncbi.nlm.nih.gov/pubmed/33050433 http://dx.doi.org/10.3390/molecules25204611 |
_version_ | 1783600136027373568 |
---|---|
author | Ezzeldin, Essam Abo-Talib, Nisreen F. Tammam, Marwa H. Asiri, Yousif A. Amr, Abd El-Galil E. Almehizia, Abdulrahman A. |
author_facet | Ezzeldin, Essam Abo-Talib, Nisreen F. Tammam, Marwa H. Asiri, Yousif A. Amr, Abd El-Galil E. Almehizia, Abdulrahman A. |
author_sort | Ezzeldin, Essam |
collection | PubMed |
description | A simple, rapid, sensitive, and precise reversed-phase liquid chromatographic method was developed and validated for the simultaneous determination of four direct-acting antivirals, sofosbuvir (SF), ledipasvir (LD), declatasvir (DC), and simeprevir (SM), in their respective pharmaceutical formulations. Effective chromatographic separation was achieved on an Agilent Eclipse plus C8 column (250 mm × 4.6 mm, 5 µm) at 40 °C with gradient elution using a mobile phase composed of acetonitrile:phosphate buffer (pH 6.5). The quantification of SF and DC was based on peak area measurements at 260 nm, while the quantification of LD and SM was achieved at 330 nm. The linearity was acceptable from 1.0 to 20.0 μg/mL for the studied drugs, with correlation coefficients >0.999. The analytical performance of the newly proposed HPLC procedure was thoroughly validated according to ICH guidelines in terms of linearity, precision (RSD%, 0.39–1.57), accuracy (98.05–101.90%), specificity, limit of detection (LOD) (0.022–0.039 μg/mL), limit of quantification (LOQ) (0.067–0.118 μg/mL), and robustness. The validated HPLC method was successfully used to analyze the abovementioned drugs in their pure and dosage forms without interference from common excipients present in commercial formulations. |
format | Online Article Text |
id | pubmed-7587186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75871862020-10-29 Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms Ezzeldin, Essam Abo-Talib, Nisreen F. Tammam, Marwa H. Asiri, Yousif A. Amr, Abd El-Galil E. Almehizia, Abdulrahman A. Molecules Article A simple, rapid, sensitive, and precise reversed-phase liquid chromatographic method was developed and validated for the simultaneous determination of four direct-acting antivirals, sofosbuvir (SF), ledipasvir (LD), declatasvir (DC), and simeprevir (SM), in their respective pharmaceutical formulations. Effective chromatographic separation was achieved on an Agilent Eclipse plus C8 column (250 mm × 4.6 mm, 5 µm) at 40 °C with gradient elution using a mobile phase composed of acetonitrile:phosphate buffer (pH 6.5). The quantification of SF and DC was based on peak area measurements at 260 nm, while the quantification of LD and SM was achieved at 330 nm. The linearity was acceptable from 1.0 to 20.0 μg/mL for the studied drugs, with correlation coefficients >0.999. The analytical performance of the newly proposed HPLC procedure was thoroughly validated according to ICH guidelines in terms of linearity, precision (RSD%, 0.39–1.57), accuracy (98.05–101.90%), specificity, limit of detection (LOD) (0.022–0.039 μg/mL), limit of quantification (LOQ) (0.067–0.118 μg/mL), and robustness. The validated HPLC method was successfully used to analyze the abovementioned drugs in their pure and dosage forms without interference from common excipients present in commercial formulations. MDPI 2020-10-10 /pmc/articles/PMC7587186/ /pubmed/33050433 http://dx.doi.org/10.3390/molecules25204611 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ezzeldin, Essam Abo-Talib, Nisreen F. Tammam, Marwa H. Asiri, Yousif A. Amr, Abd El-Galil E. Almehizia, Abdulrahman A. Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms |
title | Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms |
title_full | Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms |
title_fullStr | Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms |
title_full_unstemmed | Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms |
title_short | Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms |
title_sort | validated reversed-phase liquid chromatographic method with gradient elution for simultaneous determination of the antiviral agents: sofosbuvir, ledipasvir, daclatasvir, and simeprevir in their dosage forms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587186/ https://www.ncbi.nlm.nih.gov/pubmed/33050433 http://dx.doi.org/10.3390/molecules25204611 |
work_keys_str_mv | AT ezzeldinessam validatedreversedphaseliquidchromatographicmethodwithgradientelutionforsimultaneousdeterminationoftheantiviralagentssofosbuvirledipasvirdaclatasvirandsimeprevirintheirdosageforms AT abotalibnisreenf validatedreversedphaseliquidchromatographicmethodwithgradientelutionforsimultaneousdeterminationoftheantiviralagentssofosbuvirledipasvirdaclatasvirandsimeprevirintheirdosageforms AT tammammarwah validatedreversedphaseliquidchromatographicmethodwithgradientelutionforsimultaneousdeterminationoftheantiviralagentssofosbuvirledipasvirdaclatasvirandsimeprevirintheirdosageforms AT asiriyousifa validatedreversedphaseliquidchromatographicmethodwithgradientelutionforsimultaneousdeterminationoftheantiviralagentssofosbuvirledipasvirdaclatasvirandsimeprevirintheirdosageforms AT amrabdelgalile validatedreversedphaseliquidchromatographicmethodwithgradientelutionforsimultaneousdeterminationoftheantiviralagentssofosbuvirledipasvirdaclatasvirandsimeprevirintheirdosageforms AT almehiziaabdulrahmana validatedreversedphaseliquidchromatographicmethodwithgradientelutionforsimultaneousdeterminationoftheantiviralagentssofosbuvirledipasvirdaclatasvirandsimeprevirintheirdosageforms |